Metraipolis › archive › dc_2ccca5240695

Efficacy and Safety of Dual and Triple Glucagon-Like Peptide-1-Based Polyagonists in Metabolic Dysfunction-Associated Steatotic Liver Disease and… — Europe PMC PMID:42529769

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42529769
DOI
10.7759/cureus.111728
License (as archived)
solo-consultazione
Archived
2026-10-18T14:58:54.340Z
SHA-256 of the archived text
051b04f5a4b769b4d8f86d374cb835e56f8dc322b5cbb5f0904391dee6e8e02a
Stable URL of this page
https://metraipolis.com/documento/dc_2ccca5240695

How to cite

Efficacy and Safety of Dual and Triple Glucagon-Like Peptide-1-Based Polyagonists in Metabolic Dysfunction-Associated Steatotic Liver Disease and… — Europe PMC PMID:42529769 — Europe PMC (en), https://europepmc.org/article/MED/42529769 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2ccca5240695 (Metraipolis archive dc_2ccca5240695, sha256 051b04f5a4b769b4d8f86d374cb835e56f8dc322b5cbb5f0904391dee6e8e02a)
BibTeX
@misc{dc2ccca5240695,
  title = {Efficacy and Safety of Dual and Triple Glucagon-Like Peptide-1-Based Polyagonists in Metabolic Dysfunction-Associated Steatotic Liver Disease and… — Europe PMC PMID:42529769},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42529769},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2ccca5240695; sha256 051b04f5a4b769b4d8f86d374cb835e56f8dc322b5cbb5f0904391dee6e8e02a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42529769. Agents can read the archived copy with the MCP tool read_document.